Table 4.
Effects of different treatments on villus height
| Group | Villus height (μm) |
|||
| 3 d | 8 d | 10 d | 12 d | |
| A | 898.00±80.07a | 309.33±49.10cde | 593.00±78.00b | 672.33±36.02c |
| B | 774.67±14.01b | 788.61±11.09a | 790.32±22.10a | 789.18±12.07b |
| C | 375.33±59.23cd | 419.00±23.90c | 659.67±52.62c | |
| D | 421.33±42.57c | 393.33±44.84c | 554.67±30.86d | |
| E | 548.33±53.89b | 871.00±51.88a | 879.33±28.75a | |
| F | 303.33±25.93de | 428.67±9.29c | 528.00±16.82d | |
| G | 206.00±16.09e | 331.00±29.60c | 533.33±33.13d | |
A, CM-Pal prevention group; B, uninfected group; C, Pal group; D, montmorillonite powder group; E, CM-Pal treatment group; F, gentamicin group; G, no treatment group. Within columns, different superscripts (a–e) indicate a significant difference (P<0.05)